1,590
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Adipose-Derived Mesenchymal Stem Cells Attenuate Immune Reactions Against Pig Decellularized Bronchi Engrafted into Rat Tracheal Defects

, ORCID Icon, , , , , , , , , , , , & show all
Article: 2212582 | Received 31 Oct 2021, Accepted 05 May 2023, Published online: 15 May 2023

References

  • Aamodt JM, Grainger DW. Extracellular matrix-based biomaterial scaffolds and the host response. Biomater. 2016;86:68–16. doi:10.1016/j.biomaterials.2016.02.003.
  • Nouri Barkestani M, Naserian S, Uzan G, Shamdani S. Post-decellularization techniques ameliorate cartilage decellularization process for tissue engineering applications. J Tissue Eng. 2021;12:12–14.
  • Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomater. 2006;27:3675–83. doi:10.1016/j.biomaterials.2006.02.014.
  • Tsuchiya T, Sivarapatna A, Rocco K, Nanashima A, Nagayasu T, Niklason LE. Future prospects for tissue engineered lung transplantation: decellularization and recellularization-based whole lung regeneration. Organogenesis. 2014;10:196–207.
  • Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med. 2008;14:213–21.
  • Uygun BE, Soto-Gutierrez A, Yagi H, Izamis ML, Guzzardi MA, Shulman C, Milwid J, Kobayashi N, Tilles A, Berthiaume F, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med. 2010;16(7):814–20.
  • Petersen TH, Calle EA, Zhao L, Lee EJ, Gui L, Raredon MSB, Gavrilov K, Yi T, Zhuang ZW, Breuer C, et al. Tissue-engineered lungs for in vivo implantation. Science. 2010;329:538–41.
  • Tsuchiya T, Doi R, Obata T, Hatachi G, Nagayasu T. Lung microvascular niche, repair, and engineering. Front Bioeng Biotechnol. 2020;8:1–19.
  • Zhou H, Kitano K, Ren X, Rajab TK, Wu M, Gilpin SE, Wu T, Baugh L, Black LD, Mathisen DJ, et al. Bioengineering human lung grafts on porcine matrix. Ann Surg. 2018;267(3):590–98.
  • Lee W, Miyagawa Y, Long CL, Cooper DKC, Hara H. A comparison of three methods of decellularization of pig corneas to reduce immunogenicity. Int J Ophthalmol. 2014;7:587–93.
  • Hashimoto Y, Tsuchiya T, Doi R, Matsumoto K, Higami Y, Kobayashi E, Nagayasu T. Alteration of the extracellular matrix and alpha-gal antigens in the rat lung scaffold reseeded using human vascular and adipogenic stromal cells. J Tissue Eng Regen Med. 2019;13:2067–76.
  • Zagoura DS, Roubelakis MG, Bitsika V, Trohatou O, Pappa KI, Kapelouzou A, Antsaklis A, Anagnou NP. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut. 2012;61:894–906.
  • Bermudez MA, Sendon-Lago J, Seoane S, Eiro N, Gonzalez F, Saa J, Vizoso F, Perez-Fernandez R. Anti-inflammatory effect of conditioned medium from human uterine cervical stem cells in uveitis. Exp Eye Res. 2016;149:84–92.
  • Yañez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M, Bueren JA. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells. 2006;24:2582–91.
  • Nicola M, Di Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838–43.
  • Podestà MA, Remuzzi G, Casiraghi F. Mesenchymal stromal cells for transplant tolerance. Front Immunol. 2019;(10):1287. doi:10.3389/fimmu.2019.01287.
  • Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, et al. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107(1):367–72.
  • Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, Minelli A, Alvisi C, Vanoli A, Calliada F, et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising crohn’s disease. Gut. 2011;60(6):788–98.
  • García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA. A phase I clinical trial of the treatment of crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005;48:1416–23.
  • Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, Telkabadi M, Atashi A, Honardoost M, Zali MR, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009;21(10):1199–205.
  • Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B, Li Y, Bai W, Li M, Ji H, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(24):3192–202.
  • Duijvestein M, Vos ACW, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, Kooy-Winkelaar EMC, Koning F, Zwaginga JJ, Fidder HH, et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study. Gut. 2010;59(12):1662–69.
  • Masterson CH, Ceccato A, Artigas A, dos Santos C, Rocco PR, Rolandsson Enes S, Weiss DJ, McAuley D, Matthay MA, English K, et al. Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges. Intensive Care Med Exp. 2021;9(1). doi:10.1186/s40635-021-00424-5.
  • Papalamprou A, Chang CW, Vapniarsky N, Clark A, Walker N, Griffiths LG. Xenogeneic cardiac extracellular matrix scaffolds with or without seeded mesenchymal stem cells exhibit distinct in vivo immunosuppressive and regenerative properties. Acta Biomater. 2016;45:155–68.
  • Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 2006;24:150–54.
  • Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100:1249–60.
  • Ikegame Y, Yamashita K, Hayashi SI, Mizuno H, Tawada M, You F, Yamada K, Tanaka Y, Egashira Y, Nakashima S, et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytother. 2011;13(6):675–85.
  • De Francesco F, Tirino V, Desiderio V, Ferraro G, D’Andrea F, Giuliano M, Libondi G, Pirozzi G, De Rosa A, Papaccio G, et al. Human CD34+/CD90+ ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries. PLos One. 2009;4(8):4. doi:10.1371/journal.pone.0006537.
  • Saka Y, Furuhashi K, Katsuno T, Kim H, Ozaki T, Iwasaki K, Haneda M, Sato W, Tsuboi N, Ito Y, et al. Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production. Xenotransplant. 2011;18(3):196–208.
  • English K, Wood KJ. Mesenchymal stromal cells in transplantation rejection and tolerance. Cold Spring Harb Perspect Med. 2013;3(5):3. doi:10.1101/cshperspect.a015560.
  • Watanabe H, Tsuchiya T, Shimoyama K, Shimizu A, Akita S, Yukawa H, Baba Y, Nagayasu T. Adipose-derived mesenchymal stem cells attenuate rejection in a rat lung transplantation model. J Surg Res. 2018;227:17–27.
  • Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, Dodson A, Martorell J, Bellini S, Parnigotto PP, et al. Clinical transplantation of a tissue-engineered airway. Lancet. 2008;372(9655):2023–30.
  • Grillo HC. Surgery of the trachea and bronchi. Chirurg. 1987;58:511–20.
  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–47.
  • Bories GFP, Leitinger N. Macrophage metabolism in atherosclerosis. FEBS Lett. 2017;591:3042–60.
  • Braune J, Weyer U, Hobusch C, Mauer J, Brüning JC, Bechmann I, Gericke M. IL-6 regulates M2 polarization and local proliferation of adipose tissue macrophages in obesity. J Immunol. 2017;198:2927–34.
  • Obata T, Tsuchiya T, Akita S, Kawahara T, Matsumoto K, Miyazaki T, Masumoto H, Kobayashi E, Niklason LE, Nagayasu T. Utilization of natural detergent potassium laurate for decellularization in lung bioengineering. Tissue Eng - Part C Methods. 2019;25:459–71.
  • Mendez JJ, Ghaedi M, Steinbacher D, Niklason LE. Epithelial cell differentiation of human mesenchymal stromal cells in decellularized lung scaffolds. Tissue Eng - Part A. 2014;20:1735–46.
  • Ma H, Lam PK, Siu WS, Tong CSW, Lo KKY, Koon CM, Wu XX, Li X, Cheng W, Shum WT, et al. Adipose tissue-derived mesenchymal stem cells (Admscs) and admsc-derived secretome expedited wound healing in a rodent model – a preliminary study. Clin Cosmet Investig Dermatol. 2021;14:753–64.
  • Rasquinha MT, Sur M, Lasrado N, Reddy J. IL-10 as a Th2 cytokine: differences between mice and humans. J Immunol. 2021;207:2205–15.
  • Rochefort GY, Vaudin P, Bonnet N, Pages JC, Domenech J, Charbord P, Eder V. Influence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies? Respir Res. 2005;6:6.
  • Guess AJ, Daneault B, Wang R, Bradbury H, La Perle KMD, Fitch J, Hedrick SL, Hamelberg E, Astbury C, White P, et al. Safety profile of good manufacturing practice manufactured interferon γ-primed mesenchymal stem/stromal cells for clinical trials. Stem Cells Transl Med. 2017;6(10):1868–79.
  • Ohno M, Fuchimoto Y, Hsu HC, Higuchi M, Komura M, Yamaoka T, Umezawa A, Enosawa S, Kuroda T. Airway reconstruction using decellularized tracheal allografts in a porcine model. Pediatr Surg Int. 2017;33:1065–71.
  • Lange P, Greco K, Partington L, Carvalho C, Oliani S, Birchall MA, Sibbons PD, Lowdell MW, Ansari T. Pilot study of a novel vacuum-assisted method for decellularization of tracheae for clinical tissue engineering applications. J Tissue Eng Regen Med. 2017;11:800–11.
  • Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomater. 2011;32:3233–43.
  • Ozturk S, Ayanoğlu FB, Parmaksiz M, Elçin AE, Elçin YM. Clinical and surgical aspects of medical materials’ biocompatibility. Handb Biomater Biocompat. 2020;219–50.
  • Parmaksiz M, Dogan A, Odabas S, Elçin AE, Elçin YM. Clinical applications of decellularized extracellular matrices for tissue engineering and regenerative medicine. Biomed Mater. 2016;11:022003.
  • Tsuchiya T, Balestrini JL, Mendez J, Calle EA, Zhao L, Niklason LE. Influence of pH on extracellular matrix preservation during lung decellularization. Tissue Eng - Part C Methods. 2014;20:1028–36.
  • Gilbert TW, Freund JM, Badylak SF. Quantification of DNA in biologic scaffold materials. J Surg Res. 2009;152:135–39.
  • Allman AJ, McPherson TB, Badylak SF, Merrill LC, Kallakury B, Sheehan C, Raeder RH, Metzger DW. Xenogeneic extracellular matrix grafts elicit a Th2-restricted immune response. Transplant. 2001;71:1631–40.
  • Sun F, Pan S, Shi HC, Zhang FB, Zhang WD, Ye G, Liu XC, Zhang SQ, Zhong CH, Yuan XL. Structural integrity, immunogenicity and biomechanical evaluation of rabbit decellularized tracheal matrix. J Biomed Mater Res - Part A. 2015;103:1509–19.
  • Grove DA, Xu J, Joodi R, Torres-Gonzales E, Neujahr D, Mora AL, Rojas M. Attenuation of early airway obstruction by mesenchymal stem cells in a murine model of heterotopic tracheal transplantation. J Hear Lung Transplant. 2011;30:341–50.
  • Fiorelli-Arazawa LR, Haddad JM, Nicola MH, Machado JJ, Do S, Coimbra AC, Santamaria X, Soares JM, Baracat EC. Hormonal oral contraceptive influence on isolation, characterization and cryopreservation of mesenchymal stem cells from menstrual fluid. Gynecol Endocrinol. 2019;35:638–44.
  • Yukawa H, Kagami Y, Watanabe M, Oishi K, Miyamoto Y, Okamoto Y, Tokeshi M, Kaji N, Noguchi H, Ono K, et al. Quantum dots labeling using octa-arginine peptides for imaging of adipose tissue-derived stem cells. Biomater. 2010;31(14):4094–103.
  • Yukawa H, Noguchi H, Oishi K, Takagi S, Hamaguchi M, Hamajima N, Hayashi S. Cell transplantation of adipose tissue-derived stem cells in combination with heparin attenuated acute liver failure in mice. Cell Transplant. 2009;18:611–18.